[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mvm-fgr\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mvm-fgr":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100524133","a-cohort-of-maternal-vascular-malperfusion-related-fgr-comvmfgr-100524133",false,"NCT06104748","A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)","Inclusion Criteria:\n\n1.Singleton pregnancy 2. diagnosed as FGR according the delphi consensus:\n\n1. Early-onset FGR(\\\u003C32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \\\u003C 3rd; or EFW or AC \\\u003C 10th, combined with abnormal doppler, including uterine artery pulsatility index(UtA PI) \\>95th percentile, umbilical artery pulsatility index(UA PI) \\>95th percentile； or umbilical artery absent end-diastolic flow (UA-AEDF) or umbilical artery reversed end-diastolic flow(UA-REDF).\n2. Late-onset FGR(≥32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \\\u003C 3rd; or \\>2 of the following 3 criteria:\n\n   * EFW or AC \\\u003C10th percentile\n   * EFW or AC crossing percentiles\\>2 quartiles on growth percentiles\n   * CPR \\\u003C5th percentile or UA-Pl\\>95th percentile 3.provision of signed written informed consent.\n\nExclusion Criteria:\n\n* Fetus with definitive genetic disorders related to FGR, fetus with confirmed intrauterine infection (CMV, syphilis and etc.), fetus with structural anomalies\n* Incomplete information or absence of informed consent","FEMALE","18 Years","45 Years",{"count":19,"type":20},500,"ESTIMATED","2 Years","OBSERVATIONAL","Based on a precise diagnostic standard process, through a multicenter study, we will establish a cohort focusing on placenta-mediated fetal growth restriction (FGR). Long-term follow-up will be conducted to seek predictive indicators for short-term and long-term adverse outcomes of maternal vascular malperfusion-related FGR (MVM-FGR).",[25],"MVM-FGR",[27,28,29,30,31],"FGR","maternal vascular malperfusion","Doppler","placenta","etiologies","RECRUITING","2024-06-06",{"date":35,"type":36},"2024-06-07","ACTUAL",{"date":38,"type":36},"2023-08-10",{"date":40,"type":20},"2025-12-30",{"name":42,"class":43},"Shanghai First Maternity and Infant Hospital","OTHER"]